Bridgewater, N.J. (LabNews Media LLC) – The Metabolic Supply Group (MSG) has introduced the Metabolic Research Network (MRN), a new platform designed to connect medical facilities such as Med Spas, longevity clinics, weight loss practices, and telemedicine providers with clinical research studies in the U.S.
The platform aims to improve access to clinical trials in areas such as obesity, diabetes, cardiometabolic diseases, fatty liver disease, dermatology, hormone health, and longevity and anti-aging medicine. MRN also supports decentralized clinical trials (DCTs).
The initiative stems from the growing gap between advancing clinical research and the highly engaged patient groups already served by modern wellness and longevity offerings. Many of these patients are actively seeking innovative therapies and prevention solutions.
By connecting these groups, the platform will enable study sponsors and research institutions to find suitable participants more quickly, while participating practices gain new opportunities for patient education and to generate additional revenue through patient referrals.
“Many patients seeking treatments for weight loss, metabolic optimization, or hormone therapy often meet the criteria for innovative clinical trials,” said Alaa Salem, founder and CEO of Metabolic Supply Group. The platform allows practices to contribute to the advancement of medicine while unlocking new revenue streams, without needing to become a full-fledged study site themselves.
MRN is intended for pharmaceutical companies, biotech firms, Contract Research Organizations (CROs), academic institutions, and operators of decentralized studies. Interested healthcare providers can learn more about participation through Metabolic Supply Group.
The Metabolic Research Network is a division of Metabolic Supply Group and supports patient recruitment, study matching, and strategic research collaborations.
